Back to Industry News
Medtech
Reuters: US appeals court revives $2.5 billion opioid lawsuit
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Reuters
Photo by Shutter Speed on Unsplash
TL;DR
A U.S. appeals court revived a $2.5 billion lawsuit against Cencora, McKesson Corp., and Cardinal Health, reversing a previous ruling. The suit alleges the distributors contributed to the opioid crisis in Cabell County and Huntington, West Virginia by supplying large quantities of opioids and failing to report suspicious orders.
Key takeaways
- appeals court has reinstated a $2
- 5 billion lawsuit against drug distributors Cencora, McKesson Corp
- , and Cardinal Health, as reported by Reuters
A U.S. appeals court has reinstated a $2.5 billion lawsuit against drug distributors Cencora, McKesson Corp., and Cardinal Health, as reported by Reuters. The suit alleges the companies contributed to the opioid addiction crisis in Cabell County and the City of Huntington, West Virginia.
The 4th U.S. Circuit Court of Appeals overturned a 2022 ruling that had sided with the distributors. The appeals court determined the lower court erred in concluding the companies did not create a "public nuisance" by supplying a substantial quantity of addictive opioids to local pharmacies. The case has been remanded for re-evaluation to determine the companies' potential liability for the costs of addiction treatment and prevention programs. The ruling highlighted allegations that the companies failed to report numerous "suspicious" large orders of opioids to the U.S. Drug Enforcement Administration.
Related Topics
opioidslawsuitdrug distributorsWest Virginiaappeals court
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)